Technical Analysis for VXRT - Vaxart, Inc.

Grade Last Price % Change Price Change
F 0.61 -1.97% -0.01
VXRT closed down 1.97 percent on Wednesday, November 20, 2024, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish -1.97%
Lower Bollinger Band Walk Weakness -1.97%
Wide Bands Range Expansion -1.97%
Oversold Stochastic Weakness -1.97%
Jack-in-the-Box Bearish Bearish Swing Setup -0.36%
Lower Bollinger Band Walk Weakness -0.36%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 17 hours ago
Possible NR7 about 18 hours ago
Possible Inside Day about 18 hours ago
Down 3% about 20 hours ago
Down 2 % about 22 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Coronavirus Influenza Vaccines Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Human Papilloma Virus Human Papillomavirus Infection Vaccine Preventable Diseases

Is VXRT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.54
52 Week Low 0.52
Average Volume 1,362,518
200-Day Moving Average 0.86
50-Day Moving Average 0.79
20-Day Moving Average 0.71
10-Day Moving Average 0.66
Average True Range 0.05
RSI (14) 33.33
ADX 26.37
+DI 10.86
-DI 25.55
Chandelier Exit (Long, 3 ATRs) 0.71
Chandelier Exit (Short, 3 ATRs) 0.73
Upper Bollinger Bands 0.86
Lower Bollinger Band 0.57
Percent B (%b) 0.13
BandWidth 40.53
MACD Line -0.05
MACD Signal Line -0.04
MACD Histogram -0.0109
Fundamentals Value
Market Cap 93.24 Million
Num Shares 153 Million
EPS -0.63
Price-to-Earnings (P/E) Ratio -0.96
Price-to-Sales 43.93
Price-to-Book 2.55
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.66
Resistance 3 (R3) 0.66 0.65 0.65
Resistance 2 (R2) 0.65 0.64 0.65 0.65
Resistance 1 (R1) 0.63 0.63 0.62 0.62 0.64
Pivot Point 0.61 0.61 0.61 0.61 0.61
Support 1 (S1) 0.59 0.60 0.59 0.59 0.57
Support 2 (S2) 0.58 0.59 0.58 0.57
Support 3 (S3) 0.56 0.58 0.56
Support 4 (S4) 0.56